SMR Stock Slides As Lawsuits Mount And Backers Exit

NuScale Power Corporation stocks have been trading down by -4.44 percent amid heightened concerns over small modular reactor project delays.

Live Update At 16:02:15 EDT: On Wednesday, April 29, 2026 NuScale Power Corporation stock [NYSE: SMR] is trending down by -4.44%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

NuScale Power, trading as SMR, is showing exactly the kind of high-risk profile momentum traders watch like a hawk. On the chart, SMR has pulled back from a recent spike near $14 on 2026/04/23 to around $11.30 at the latest close, giving back a big chunk of that run. Daily candles over the last few weeks show wide ranges and repeated failed pushes above the mid-$13s, signaling heavy selling pressure overhead.

Intraday, SMR spent most of the latest session grinding between $11.00 and $11.30, with tight 5‑minute candles and no real breakout attempt after the opening fade. That’s classic consolidation after a hard pullback, but with a bearish tilt because every bounce keeps stalling below prior resistance.

More Breaking News

• Trade Desk Stock Slides As Legal Risks Mount And AI Bets Deepen
• BZAI Stock Slides As Traders Gauge High-Risk AI Setup
• REPL Stock Collapses As FDA Rejects RP1 Melanoma Bid
• IQST Stock Slips As Traders Weigh Weak Margins And Heavy Losses

Under the hood, NuScale Power’s fundamentals are still deep in the red. Revenue sits at roughly $31.5M, yet key profitability margins are massively negative, and SMR posts return on equity near minus 40%. The company carries no debt and a strong current ratio around 4.3, so liquidity looks fine. But a price‑to‑sales ratio near 138 tells traders the market is paying a steep premium for a story that is not yet supported by earnings. For short-term trading, SMR is a volatility play, not a value name.

Why Traders Are Watching SMR Now

SMR is back in the spotlight because the story has shifted from clean-energy promise to legal and credibility risk. Multiple securities-fraud class actions claim NuScale Power misled the market about ENTRA1 Energy, the company it leaned on as an exclusive commercialization partner for its small modular reactor projects. The suits say ENTRA1 lacked real nuclear project experience, yet SMR still committed massive capital and tied its deployment strategy to that partner.

The breaking point was Q3 2025. NuScale Power reported general and administrative expenses exploding more than 3,000% to $519M, almost entirely due to a single $495M payment to ENTRA1 connected to a Tennessee Valley Authority nuclear development agreement. That one check turned into a quarterly net loss of $532M and a double‑digit drop in SMR’s share price over just a few sessions. From there, according to the complaints, NuScale Power slid more than 70% from above $57 to about $17 during the May–November 2025 window.

For traders, this is textbook sentiment collapse. SMR is dealing not just with a bad quarter, but with ongoing class actions, reminders of an 2026/04/20 lead‑plaintiff deadline, and now serious questions about management’s judgment and disclosure. Add the fact that Fluor has completely unwound its roughly 40M‑share stake—about $2.43B in stock sold since 2025/09—and you have a former anchor shareholder walking away. Citi cutting its SMR price target to $9 and sticking with a Sell rating only reinforces that big money remains skeptical. This combination of legal overhang, fundamental losses, and flagging sponsorship is exactly why short-biased and event-driven traders are locked in on SMR’s tape right now.

Conclusion

NuScale Power and SMR are a live case study in how fast a hot story can unwind when execution and transparency break down. The ENTRA1 saga, the $495M milestone payment, and the resulting $532M quarterly loss have turned what was supposed to be a breakthrough commercialization step into a long-tail legal and credibility drag. With SMR still trading at a rich sales multiple despite heavy losses, every new court filing or headline around ENTRA1 and TVA becomes a potential catalyst.

At the same time, Fluor’s full exit from its NuScale stake and Citi’s Sell rating remind traders that key institutions are stepping back rather than defending the name. That loss of sponsorship changes how the market treats every bounce in SMR—more like a shorting opportunity than a vote of confidence. For active traders, the focus now is on price action around key levels near $11 and $9, and on any updates to the class actions or project pipeline. In this kind of tape, the priority is staying reactive rather than predictive—waiting for the stock to confirm a thesis through volume and trend before committing real capital.

As Tim Sykes loves to hammer home, “The market doesn’t care about your beliefs, it cares about the truth revealed in price action.” That dovetails with the mindset captured by As Tim Bohen, lead trainer with StocksToTrade says, “I focus on what a stock is doing, not what I want it to do. Let the stock prove itself before you make a move.”. For SMR, that truth is a bearish trend with legal landmines. The edge for traders is not guessing the long-term outcome, but respecting the volatility, cutting losses fast, and letting the chart—not the story—tell you when the tide finally turns. This analysis is for educational and research purposes only and is not investment advice.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

• How to Read Stock Charts: A Guide for Beginners
• Trading Plan: 6 Steps to Create One
• How To Create a Stock Watchlist

Ready to build your watchlists? Check out these curated lists:

• AI Penny Stocks
• Robinhood Penny Stocks
• Top Biotech Stocks

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.